PG
P&G did what P&G does
Procter & Gamble rolled out fiscal third-quarter results and, surprise surprise, it looked a lot like a giant consumer staples company doing giant consumer staples things: sales were up, organic growth was positive, and the share count drama stayed in the background.
Net sales came in at $21.2 billion, a 7% jump from a year ago. Strip out currency swings and portfolio changes, and organic sales still rose 3%, which is the number investors usually squint at when they want to know whether the business is actually humming or just getting a little help from the financial blender.
The EPS boost had a little extra spice
Diluted earnings per share landed at $1.63, up 6% year over year. But there’s a catch: part of that lift came from a gain tied to the dissolution of the Glad joint venture business. Translation: the quarter wasn’t just about cleaner execution; there was also a one-time boost making the numbers look a bit shinier.
Why you should care
For a company like P&G, the bar isn’t “wow us.” It’s “keep the machine running without breaking anything.” This quarter says the machine is still chugging:
- sales growth stayed positive
- organic growth was in the green
- earnings improved, even if not all of it was purely operational
That matters because P&G is the kind of stock people buy when they want fewer fireworks and more boring competence. And in this market, boring competence can still get applause.
Big picture: P&G didn’t deliver a moonshot — it delivered proof that its brand-and-pricing playbook still works.